- Home
- FET vs PRQR Comparison
FET vs PRQR Comparison
Compare FET & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- PRQR
- Stock Information
- Founded
- FET 2005
- PRQR 2012
- Country
- FET United States
- PRQR Netherlands
- Employees
- FET N/A
- PRQR N/A
- Industry
- FET Metal Fabrications
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FET Industrials
- PRQR Health Care
- Exchange
- FET Nasdaq
- PRQR Nasdaq
- Market Cap
- FET 240.1M
- PRQR 244.4M
- IPO Year
- FET 2012
- PRQR 2014
- Fundamental
- Price
- FET $20.41
- PRQR $2.23
- Analyst Decision
- FET
- PRQR Strong Buy
- Analyst Count
- FET 0
- PRQR 8
- Target Price
- FET N/A
- PRQR $8.88
- AVG Volume (30 Days)
- FET 80.2K
- PRQR 224.5K
- Earning Date
- FET 08-07-2025
- PRQR 08-07-2025
- Dividend Yield
- FET N/A
- PRQR N/A
- EPS Growth
- FET N/A
- PRQR N/A
- EPS
- FET N/A
- PRQR N/A
- Revenue
- FET $807,312,000.00
- PRQR $21,212,711.00
- Revenue This Year
- FET N/A
- PRQR N/A
- Revenue Next Year
- FET $1.56
- PRQR N/A
- P/E Ratio
- FET N/A
- PRQR N/A
- Revenue Growth
- FET 7.31
- PRQR 85.91
- 52 Week Low
- FET $12.78
- PRQR $1.07
- 52 Week High
- FET $21.57
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FET 62.59
- PRQR 52.77
- Support Level
- FET $19.12
- PRQR $2.16
- Resistance Level
- FET $20.11
- PRQR $2.28
- Average True Range (ATR)
- FET 0.69
- PRQR 0.14
- MACD
- FET -0.03
- PRQR -0.03
- Stochastic Oscillator
- FET 75.47
- PRQR 30.08
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.